ARTICLE | Company News
AMDL diagnostic news
August 24, 2009 7:00 AM UTC
AMDL said it plans to shift its focus from distributing pharmaceuticals in China to developing and commercializing its marketed in vitro cancer diagnostic Onko-Sure (formerly DR-70) and its Elleuxe skin care products. The company also plans to change its name to Radient Pharmaceuticals Corp. ...